HIF-1α is essential for myeloid cell-mediated inflammation

被引:1732
作者
Cramer, T
Yamanishi, Y
Clausen, BE
Förster, I
Pawlinski, R
Mackman, N
Haase, VH
Jaenisch, R
Corr, M
Nizet, V
Firestein, GS
Gerber, HP
Ferrara, N
Johnson, RS [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Med, Div Rheumatol, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Sch Med, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA
[4] Univ Amsterdam, Dept Cell Biol & Histol, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands
[5] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany
[6] Scripps Res Inst, Dept Immunol, San Diego, CA 92037 USA
[7] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[8] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA
[9] MIT, Dept Biol, Cambridge, MA 02139 USA
[10] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1016/S0092-8674(03)00154-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Granulocytes and monocytes/macrophages of the myeloid lineage are the chief cellular agents of innate immunity. Here, we have examined the inflammatory response in mice with conditional knockouts of the hypoxia responsive transcription factor HIF-1alpha, its negative regulator VHL, and a known downstream target, VEGF. We find that activation of HIF-1alpha is essential for myeloid cell infiltration and activation in vivo through a mechanism independent of VEGF. Loss of VHL leads to a large increase in acute inflammatory responses. Our results show that HIF-1alpha is essential for the regulation of glycolytic capacity in myeloid cells: when HIF-1alpha is absent, the cellular ATP pool is drastically reduced. The metabolic defect results in profound impairment of myeloid cell aggregation, motility, invasiveness, and bacterial killing. This role for HIF-1alpha demonstrates its direct regulation of survival and function in the inflammatory microenvironment.
引用
收藏
页码:645 / 657
页数:13
相关论文
共 67 条
[1]  
ARNOLD F, 1987, BRIT J EXP PATHOL, V68, P569
[2]   Phagocytes and oxidative stress [J].
Babior, BM .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (01) :33-44
[3]  
BAKKER A., 1927, KLIN WOCHENSCHR, V6, P252, DOI 10.1007/BF01710710
[4]   ENERGY-METABOLISM OF HUMAN-NEUTROPHILS DURING PHAGOCYTOSIS [J].
BORREGAARD, N ;
HERLIN, T .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (03) :550-557
[5]   EFFECT OF 2-DEOXYGLUCOSE ON GUINEA-PIG POLYMORPHONUCLEAR LEUKOCYTE PHAGOCYTOSIS [J].
BOXER, LA ;
BAEHNER, RL ;
DAVIS, J .
JOURNAL OF CELLULAR PHYSIOLOGY, 1977, 91 (01) :89-102
[6]   MEASUREMENT OF CUTANEOUS INFLAMMATION - ESTIMATION OF NEUTROPHIL CONTENT WITH AN ENZYME MARKER [J].
BRADLEY, PP ;
PRIEBAT, DA ;
CHRISTENSEN, RD ;
ROTHSTEIN, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (03) :206-209
[7]   Expression of HIF-Iα by human macrophages:: implications for the use of macrophages in hypoxia-regulated cancer gene therapy [J].
Burke, B ;
Tang, N ;
Corke, KP ;
Tazzyman, D ;
Ameri, K ;
Wells, M ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (02) :204-212
[8]  
Buttgereit F, 2000, IMMUNOL TODAY, V21, P192
[9]   Conditional gene targeting in macrophages and granulocytes using LysMcre mice [J].
Clausen, BE ;
Burkhardt, C ;
Reith, W ;
Renkawitz, R ;
Förster, I .
TRANSGENIC RESEARCH, 1999, 8 (04) :265-277
[10]  
Denko NC, 2001, CANCER RES, V61, P795